Solveig Sakshaug

918 total citations
26 papers, 704 citations indexed

About

Solveig Sakshaug is a scholar working on Economics and Econometrics, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Solveig Sakshaug has authored 26 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 5 papers in Psychiatry and Mental health and 4 papers in Oncology. Recurrent topics in Solveig Sakshaug's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (4 papers) and Cancer Risks and Factors (3 papers). Solveig Sakshaug is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (4 papers) and Cancer Risks and Factors (3 papers). Solveig Sakshaug collaborates with scholars based in Norway, Sweden and United States. Solveig Sakshaug's co-authors include Svetlana Skurtveit, Merete Grung, Torsten Källqvist, Kevin V. Thomas, Sidsel Graff‐Iversen, Kari Furu, Marit Rønning, Christian Berg, Solveig Hofvind and Giske Ursin and has published in prestigious journals such as Journal of Nutrition, International Journal of Cancer and International Journal of Environmental Research and Public Health.

In The Last Decade

Solveig Sakshaug

24 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Solveig Sakshaug Norway 14 165 163 112 86 78 26 704
Dieter Paffrath Germany 16 80 0.5× 90 0.6× 47 0.4× 30 0.3× 25 0.3× 24 683
Juan Carlos Martı́n-Escudero Spain 24 127 0.8× 46 0.3× 314 2.8× 421 4.9× 78 1.0× 104 1.6k
Anna Szymańska–Chabowska Poland 16 33 0.2× 45 0.3× 80 0.7× 123 1.4× 187 2.4× 40 779
Paolo Di Giosia Italy 16 39 0.2× 39 0.2× 249 2.2× 263 3.1× 25 0.3× 27 1.3k
Meng Lu China 17 53 0.3× 19 0.1× 48 0.4× 240 2.8× 50 0.6× 32 893
Qingyang Shi China 15 51 0.3× 15 0.1× 79 0.7× 138 1.6× 21 0.3× 35 812
Carl Gustaf Elinder Sweden 15 202 1.2× 26 0.2× 119 1.1× 479 5.6× 23 0.3× 19 1.1k
Sina Kianoush United States 19 48 0.3× 23 0.1× 367 3.3× 160 1.9× 36 0.5× 55 1.3k
Ying Wen China 19 54 0.3× 29 0.2× 47 0.4× 318 3.7× 19 0.2× 54 842

Countries citing papers authored by Solveig Sakshaug

Since Specialization
Citations

This map shows the geographic impact of Solveig Sakshaug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solveig Sakshaug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solveig Sakshaug more than expected).

Fields of papers citing papers by Solveig Sakshaug

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solveig Sakshaug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solveig Sakshaug. The network helps show where Solveig Sakshaug may publish in the future.

Co-authorship network of co-authors of Solveig Sakshaug

This figure shows the co-authorship network connecting the top 25 collaborators of Solveig Sakshaug. A scholar is included among the top collaborators of Solveig Sakshaug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solveig Sakshaug. Solveig Sakshaug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rønning, Marit, Vidar Hjellvik, Solveig Sakshaug, et al.. (2022). Use of Statins in Kidney Transplant Recipients in Norway. International Journal of Environmental Research and Public Health. 19(3). 1370–1370.
2.
Skurtveit, Svetlana, Vidar Hjellvik, Solveig Sakshaug, et al.. (2020). Forskrivning av opioider på blå resept mot langvarige smerter. Tidsskrift for Den norske legeforening. 140(15). 6 indexed citations
3.
Egeland, Grace M., Svetlana Skurtveit, Solveig Sakshaug, et al.. (2017). Low Calcium Intake in Midpregnancy Is Associated with Hypertension Development within 10 Years after Pregnancy: The Norwegian Mother and Child Cohort Study. Journal of Nutrition. 147(9). 1757–1763. 17 indexed citations
4.
Botteri, Edoardo, Nathalie C. Støer, Solveig Sakshaug, et al.. (2017). Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway. BMJ Open. 7(11). e017639–e017639. 31 indexed citations
5.
Botteri, Edoardo, Nathalie C. Støer, Solveig Sakshaug, et al.. (2017). Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?. International Journal of Cancer. 141(9). 1763–1770. 39 indexed citations
6.
Román, Marta, Sidsel Graff‐Iversen, Elisabete Weiderpass, et al.. (2016). Postmenopausal Hormone Therapy and Breast Cancer Prognostic Characteristics: A Linkage between Nationwide Registries. Cancer Epidemiology Biomarkers & Prevention. 25(11). 1464–1473. 8 indexed citations
7.
Sakshaug, Solveig, Marte Handal, Vidar Hjellvik, et al.. (2016). Long‐term Use of Z‐Hypnotics and Co‐medication with Benzodiazepines and Opioids. Basic & Clinical Pharmacology & Toxicology. 120(3). 292–298. 26 indexed citations
8.
Handal, Marte, et al.. (2015). Kjønnsforskjeller i bruk av vanedannende legemidler i Norge. BIBSYS Brage (BIBSYS (Norway)). 2 indexed citations
9.
Hofvind, Solveig, Solveig Sakshaug, Giske Ursin, & Sidsel Graff‐Iversen. (2011). Breast cancer incidence trends in Norway—explained by hormone therapy or mammographic screening?. International Journal of Cancer. 130(12). 2930–2938. 23 indexed citations
10.
Godman, Brian, Solveig Sakshaug, Christian Berg, Björn Wettermark, & Alan Haycox. (2011). Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs. Expert Review of Pharmacoeconomics & Outcomes Research. 11(1). 121–129. 46 indexed citations
11.
Godman, Brian, Rickard E. Malmström, Marion Bennie, et al.. (2011). Prescribing restrictions – a necessary strategy among some European countries to enhance future prescribing efficiency?. 3(1). 5–5. 6 indexed citations
12.
Godman, Brian, Rickard E. Malmström, Marion Bennie, et al.. (2011). Prescribing restrictions – a necessary strategy among some European countries to enhance future prescribing efficiency?. 3(1). 5–16. 28 indexed citations
13.
Selmer, Randi, Solveig Sakshaug, Svetlana Skurtveit, Kari Furu, & Aage Tverdal. (2008). Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education. British Journal of Clinical Pharmacology. 67(3). 355–362. 28 indexed citations
14.
Sakshaug, Solveig, Kari Furu, Øystein Karlstad, Marit Rønning, & Svetlana Skurtveit. (2007). Switching statins in Norway after new reimbursement policy – a nationwide prescription study. British Journal of Clinical Pharmacology. 64(4). 476–481. 71 indexed citations
15.
Grung, Merete, Torsten Källqvist, Solveig Sakshaug, Svetlana Skurtveit, & Kevin V. Thomas. (2007). Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicology and Environmental Safety. 71(2). 328–340. 181 indexed citations
16.
Hartz, Ingeborg, Solveig Sakshaug, Kari Furu, et al.. (2007). Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study. PubMed. 7(1). 14–14. 28 indexed citations
17.
Strøm, Hanne, et al.. (2006). Hvor mange og hvem behandles medikamentelt for diabetes mellitus. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
18.
Strøm, Hanne, et al.. (2006). [How many and who are receiving medication for diabetes mellitus?].. PubMed. 126(6). 768–70. 10 indexed citations
19.
Bramness, Jørgen G., et al.. (2005). Forskrivning av selektive serotoninreopptakshemmere 1990 – 2004. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
20.
Bramness, Jørgen G., et al.. (2005). [Prescription of selective serotonin reuptake inhibitors 1990-2004].. PubMed. 125(18). 2470–3. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dieter Paffrath Breakdown of academic impact, for papers by Juan Carlos Martı́n-Escudero Breakdown of academic impact, for papers by Anna Szymańska–Chabowska Breakdown of academic impact, for papers by Paolo Di Giosia Breakdown of academic impact, for papers by Meng Lu Breakdown of academic impact, for papers by Qingyang Shi Breakdown of academic impact, for papers by Carl Gustaf Elinder Breakdown of academic impact, for papers by Sina Kianoush Breakdown of academic impact, for papers by Ying Wen
Rankless by CCL
2026